Skip to main content
WELLBIOTEC CO.,LTD logo

WELLBIOTEC CO.,LTD — Investor Relations & Filings

Ticker · 010600 ISIN · KR7010600005 KO Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2020-02-17 Proxy Solicitation & In…
Country KR South Korea
Listing KO 010600

About WELLBIOTEC CO.,LTD

http://www.wellbiotec.com/?language=eng

WELLBIOTEC CO.,LTD. is a diversified company with operations in several sectors. Its business activities include the development and distribution of biopharmaceutical products, such as specialized medicines, health functional foods, and diagnostic kits. The company is also involved in the electric vehicle (EV) charging business and logistics. Additionally, it manufactures and sells leather products for fashion goods, including shoes and handbags.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Solicitation of Proxy' (위임권유) filed by Well Biotech Co., Ltd. It contains details regarding the upcoming shareholder meeting, including the agenda (election of directors, amendment of articles of incorporation), information about the proxy solicitors, and the purpose of the solicitation. This aligns perfectly with the definition of a Proxy Solicitation & Information Statement (PSI).
2020-02-17 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and Korea Exchange. It details the acquisition of convertible bonds by Baro Saving Bank in Well Biotech Co., Ltd., which constitutes a change in significant share ownership (crossing the 5% threshold). This falls under the 'Major Shareholding Notification' category.
2020-01-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including major shareholding notifications and changes in special relationships. This falls under the 'Major Shareholding Notification' category.
2020-01-15 Korean
유상증자또는주식관련사채등의발행결과(자율공시)
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory filing from a Korean company (Well Biotech) detailing the results of a private placement of convertible bonds (a type of capital financing). It specifies the issuance amount, payment date, and the nature of the securities. This falls under the category of capital and financing updates.
2020-01-10 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange regarding the issuance of convertible bonds (전환사채권 발행결정). It details the terms of the bond, interest rates, conversion rights, and the use of proceeds. This falls under capital structure changes and financing activities, which is classified as CAP (Capital/Financing Update).
2020-01-09 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for the company 'Wellbiotech'. It details the date, location, and agenda items, specifically focusing on the appointment of new directors and amendments to the articles of incorporation (business purpose changes). This type of document is a standard proxy solicitation or notice of meeting material provided to shareholders to inform them of upcoming voting matters. Given the specific categories provided, 'Proxy Solicitation & Information Statement' (PSI) is the most accurate classification for a notice of a shareholder meeting and its agenda.
2019-12-20 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.